FDA Adverse Event Malfunction Summary report: N

ARCHITECT STAT HIGH SENSITIVE TROPONIN-I

MDR report key: 24472055 · Received February 27, 2026

Report

Report Number
3005094123-2026-00100
Event Type
Malfunction
Date Received
February 27, 2026
Date of Event
February 17, 2026
Report Date
May 11, 2026
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
MMI
UDI-DI
00380740118075
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EI
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SECTION A PATIENT INFORMATION: REFER TO SECTION B5 FOR COMPLETE PATIENT INFORMATION. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 3P25 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 2R98, WITH 510K NUMBER K191595.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSE POSITIVE ARCHITECT TROPONIN RESULTS GENERATED ON AN ARCHITECT I2000SR ANALYZER, (B)(6) FOR A 58-YEAR-OLD PATIENT. THE PATIENT WAS ADMITTED TO THE HOSPITAL AND REFERRED TO CARDIOLOGY. NO REASON COULD BE FOUND FOR THE HIGH TROPONIN RESULTS. THE FOLLOWING RESULTS WERE PROVIDED (CUTOFF <34 NG/L): SID: (B)(6): (B)(6), (B)(6) 2026 TROPONIN I RESULTS = 298 NG/L AND 296 NG/L. SID: (B)(6): (B)(6), (B)(6) 2026 TROPONIN I = 314 NG/L AND 321 NG/L ROCHE TNT <16 (NORMAL). HISTORICAL RESULTS FOR THE PATIENT RUN ON (B)(6): (B)(6) 2023 TROPONIN I RESULTS = 276 NG/L, 276 NG/L, 257 NG/L, (B)(6) 2023 TROPONIN I RESULT = 234 NG/L, (B)(6) 2023 TROPONIN I RESULT = 249 NG/L, (B)(6) 2025 TROPONIN I RESULT = 324 NG/L, (B)(6) 2025 TROPONIN I RESULT = 308 NG/L, (B)(6) 2025 TROPONIN I RESULT = 295 NG/L. THERE WAS NO IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
92647 ARCHITECT STAT HIGH SENSITIVE TROPONIN-I IMMUNOASSAY METHOD, TROPONIN SUBUNIT MMI ABBOTT IRELAND DIAGNOSTICS DIVISION 83089UD00 00380740118075

Patients

Seq Age Sex Outcome Treatment
1 58 YR Male ARC I2SR REFURB-SEKAT, 03M74-97, (B)(6)